Edwards Lifesciences (EW) EV/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 25.6 | 23.3 | 29.5 | 23.8 | 32.4 | 31.5 | ||
| Changes by years, y/y, % | -39% | -9% | +27% | -19% | +36% | -9.1% | |||
Edwards Lifesciences. EV/EBITDA
Edwards Lifesciences. EV/EBITDA, changes, %
Edwards Lifesciences (EW) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 21.7 | 23.9 | 24.3 | 33.0 | 31.1 | 31.5 | |
| Changes by years, y/y, % | -40% | -27% | +14% | +43% | +43% | |||
| Changes by quarters, q/q, % | -6% | +10% | +2% | +36% | -6% | |||